Home » ETF » CHNA

CHNA - Loncar China BioPharma ETF

Stock Price: $38.35 USD 0.45 (1.17%)
Updated Apr 21, 2021 4:00 PM EDT - Market closed
After-hours: $38.96 +0.61 (1.59%) Apr 21, 4:00 PM
Assets $15.16M
NAV $37.90
Expense Ratio 0.79%
PE Ratio n/a
Beta (5Y) 0.80
Dividend (ttm) $0.16
Dividend Yield 0.41%
Ex-Dividend Date Dec 30, 2020
1-Year Return -
Trading Day April 21
Last Price $38.35
Previous Close $37.91
Change ($) 0.45
Change (%) 1.17%
Day's Open 38.35
Day's Range 38.35 - 38.35
Day's Volume 320
52-Week Range 23.73 - 42.00

Fund Description

The investment seeks to track the performance, before fees and expenses, of the Loncar China BioPharma Index (the index). Under normal circumstances, at least 80% of the fund's total assets (exclusive of any collateral held from securities lending) will be invested in the component securities of the index or in depositary receipts representing such component securities. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries. The fund is non-diversified.

Asset Class
Inception Date
Aug 14, 2018
Ticker Symbol
Index Tracked
LCHINA index

Top 10 Holdings

24.97% of assets
Kintor Pharmaceutical Ltd Ordinary Shares9939.HK3.23%
CSPC Pharmaceutical Group Ltd1093.HK2.82%
CanSino Biologics Inc Class H6185.HK2.82%
Sino Biopharmaceutical Ltd1177.HK2.63%
WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S2269.HK2.29%
Pharmaron Beijing Co Ltd Ordinary Shares - Class H3759.HK2.27%
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H2196.HK2.24%
Shanghai Junshi Biosciences Co Ltd Class H1877.HK2.24%
China Medical System Holdings Ltd867.HK2.21%
View More Holdings


Ex-DividendAmountPay Date
Dec 30, 2020$0.155Jan 4, 2021
Dec 23, 2019$0.04024942Dec 26, 2019
Full Dividend History


Hide News

Check these China ETFs that beat the S&P 500 in the past week, which was U.S. equities?

Other tickers mentioned: CHIC, KFYP, KWEB
1 year ago - Zacks Investment Research

The best pharmaceutical ETFs for Q1 2020 are KURE, CHIH, and CHNA.

Other tickers mentioned: CHIH, KURE
1 year ago - Investopedia

Policy easing in the Chinese economy, cooling trade tensions with the United States and Beijing's efforts for more urbanization have boosted these sector ETFs in 2019.

2 years ago - Zacks Investment Research